Skip to main content
ASKA Pharmaceutical Holdings Co., Ltd.ASKA Pharmaceutical Holdings Co., Ltd.
  • Contact Us
  • Accessibility
LANGUAGE
JP
EN
  • HOME
    • About ASKA Pharmaceutical Holdings
      • Top Message
      • Corporate Philosophy
      • Company Overview
      • Charter of Corporate Behavior
      • Leadership
      • Company Information
      • Group Companies
      • Business Activities
      • Corporate Message
      • Digital Transformation
      • ASKA Pharmaceutical Holdings in Numbers
    • For Our Shareholders and Investors
      • Top Message
      • IR News
      • IR Library
      • IR Calendar
      • Management Strategies and Policies
      • Governance
      • Financial Highlights
      • ASKA Pharmaceutical Holdings at a glance
      • IR Related Information
      • Stock and Shareholder Information
    • Sustainability
      • Our Sustainability
      • Environmental
      • Social
      • Governance (Related Link)
      • ESG Chart and ESG Data Book
      • External Evaluation
      • Initiatives and Member Organizations
      • Third-party Opinion
      • Sustainability News
      • Various Contrasting Tables
      • Policies (Related Link)
      • Integrated Report (Related Link)
    • Press Releases
    • Contact Us
    • Privacy Policy
    • Basic Policy on the Proper Handling of Specific Personal Information, etc.
    • Terms of Use
    • Web Accessibility Policy
    • SNS Community Guidelines
      • Official website and SNS
    • Sitemap
    • Search Results
    • Important Notice
About ASKA Pharmaceutical Holdings
  • Company Overview
  • Group Companies
  • Top Message
  • Corporate Philosophy
  • Charter of Corporate Behavior
  • Leadership
  • Company Information
  • Business Activities
  • Corporate Message
  • Digital Transformation
  • ASKA Pharmaceutical Holdings in Numbers
For Our Shareholders and Investors
  • Top Message
  • Management Strategies and Policies
  • IR News
  • IR Library
  • IR Calendar
  • Governance
  • Financial Highlights
  • ASKA Pharmaceutical Holdings at a glance
  • IR Related Information
  • Stock & Shareholder Information
Sustainability
  • Integrated Report (Related links)
  • Our Basic Policy for Sustainability
  • Various Contrasting Tables
  • Our Sustainability
    • Top Commitment
    • Our Basic Policy for Sustainability
    • Materiality
    • Value Creation Process
    • Capital and Strengths
    • Initiatives for Sustainability and SDGs
    • Importance of Female Healthcare and Social Issues
    • Disclosures based on TCFD recommendations
    • Disclosures based on TNFD recommendations
  • Environmental Governance (Related links) External Evaluation Third-party Opinion Various Contrasting Tables Integrated Report (Related links)
  • Social ESG Chart and ESG Data Book Initiatives and Member Organizations Sustainability News Policies (Related links)
HOME>HOME>For Our Shareholders and Investors>IR Library>Financial Results and IR Events>Video Library

Video Library

PRINT

Webcast of Financial Results Meeting

FY2025 (held on May 20,2026)

Transcript of Financial Results and Mid-Term Management Plan Presentation for FY2025 (including Q&A) [PDF]

Financial Results and IR Events

  • About ASKA Pharmaceutical Holdings
    • Top Message
    • Corporate Philosophy
    • Company Overview
    • Charter of Corporate Behavior
    • Leadership
    • Company Information
      • Company Information
      • Organization Chart
      • Corporate History
      • Access Map
      • Policies
      • Video Library
      • Media Library
    • Group Companies
    • Business Activities
    • Corporate Message
    • Digital Transformation
    • ASKA Pharmaceutical Holdings in Numbers
  • For Our Shareholders and Investors
    • Top Message
    • IR News
    • IR Library
      • IR Library
      • Financial Results and IR Events
        • Video Library
      • Annual Securities Report
      • Integrated Report
      • Fact Sheet
      • Corporate Governance Report (Japanese version only, Related links)
      • Internal Control Report (Japanese version only, Related links)
      • Stock and Shareholder Information (Related links)
    • IR Calendar
    • Management Strategies and Policies
      • Management Strategies and Policies
      • Long-Term Vision ASKA VISION 2035
      • Medium-Term Management Plan
      • Pipeline and Intellectual Property
      • Business Risks
      • Disclosure Policy
      • IR Basic Policy
      • Disclaimer
    • Governance
      • Governance
      • Basic Principles / Corporate Governance Structure
      • Corporate Governance Basic Policy
      • Corporate Governance Report (Japanese version only)
      • Board Members
      • Compliance / Risk Management
      • Internal Control System
      • Internal Control Report (Japanese version only)
      • Dialogue with Shareholders
      • Message from Outside Directors
    • Financial Highlights
      • Financial Highlights
      • Performance Review
      • Performance Highlights
      • Financial Conditions
      • Financial Statements
        • Consolidated Balance Sheets
        • Consolidated Statements of Income
        • Consolidated Statements of Cash Flows
      • Earnings Forecast
    • ASKA Pharmaceutical Holdings at a glance
      • ASKA Pharmaceutical Holdings at a glance
      • Point1 About ASKA - Understanding & History -
      • Point2 About ASKA - Our Strengths -
      • Point3 Highly Specialized Product Lineup
      • Point4 Continuously Evolving R&D
      • Point5 Stable Shareholder Returns
      • Frequently Asked Questions
      • Business Model
      • ASKA's Management Strategy
      • Medicine & Body Glossary
      • IR seminar for Individual Investors
    • IR Related Information
      • IR Related Information
      • IR E-mail Newsletter Service
      • IR Site Map
      • Recommended Route to Access Our IR Website
      • How to Use the IR Site
      • IR Inquiries
      • External Evaluation (IR)
    • Stock and Shareholder Information
      • Stock and Shareholder Information
      • Stock Summary Information
      • Shareholder Information
      • Shareholders' Meeting
      • Stock Price Information
      • Shareholder Return
      • Stock Procedures (Japanese version only)
      • Articles of Incorporation and Stock Handling Regulations
      • Analyst Coverage
      • Corporate Bonds and Ratings Information
      • Shareholder Newsletters (Japanese version only)
      • Privacy Policy (Shareholders)
  • Sustainability
    • Our Sustainability
      • Our Sustainability
      • Top Commitment
      • Our Basic Policy for Sustainability
      • Materiality
      • Value Creation Process
      • Capital and Strengths
      • Initiatives for Sustainability and SDGs
      • Importance of Female Healthcare and Social Issues
      • Disclosures based on TCFD recommendations
      • Disclosures based on TNFD recommendations
    • Environmental
      • Environmental
      • Environmental Management
      • Disclosures Based on TCFD Recommendations
      • Disclosures based on TNFD recommendations
      • Decarbonization Initiatives
      • Initiatives for Water Resource
      • Initiatives for Recycle-Oriented Society and Biodiversity
    • Social
      • Social
      • Stakeholder Engagement
      • Respect for Human Rights
      • Human capital/Labour Practices
      • Diversity & Inclusion
      • Initiatives to Promote the Advancement of Women
      • Health Management Initiatives
      • Ethics and Compliance
      • Supply Chain
      • Customer Health and Safety
      • Social Contribution Activities（Community Involvement and Development）
      • Multi-Stakeholder Policy
    • Governance (Related Link)
    • ESG Chart and ESG Data Book
    • External Evaluation
    • Initiatives and Member Organizations
    • Third-party Opinion
    • Sustainability News
    • Various Contrasting Tables
    • Policies (Related Link)
    • Integrated Report (Related Link)
  • Press Releases
  • Contact Us
  • Privacy Policy
  • Basic Policy on the Proper Handling of Specific Personal Information, etc.
  • Terms of Use
  • Web Accessibility Policy
  • SNS Community Guidelines
    • Official website and SNS
  • Sitemap
  • Search Results
  • Important Notice
  • Privacy Policy
  • Basic Policy on the Proper Handling of Specific Personal Information, etc.
  • Terms of Use
  • Web Accessibility Policy
  • SNS Community Guidelines
  • Sitemap
Copyright © ASKA Pharmaceutical Holdings Co., Ltd. All Rights Reserved.
TOP
k0ILfjaJ88dBJDKZ0ZXwnvz8VsCcz1DGlbZL-KEf2mM=.html